carbostyril has been researched along with Pneumonia, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baby, K; Maity, S; Mehta, CH; Nayak, UY; Nayak, Y; Suresh, A | 1 |
| Bai, L; Cao, B; Gonzalez, R; Guo, P; Liu, YM; Ren, LL; Song, SF; Wang, C; Wang, JW; Yin, YD; Zhang, JZ; Zhang, YY; Zhao, F | 1 |
2 other study(ies) available for carbostyril and Pneumonia, Viral
| Article | Year |
|---|---|
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An
Topics: Antiviral Agents; Betacoronavirus; Catalytic Domain; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Molecular Docking Simulation; Pandemics; Pentanoic Acids; Pneumonia, Viral; Pyridines; Quinolines; Quinolones; RNA-Dependent RNA Polymerase; SARS-CoV-2 | 2020 |
Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China.
Topics: Adult; Age Factors; Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Female; Humans; Legionella pneumophila; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Viral; Quinolones; Sputum; Streptococcus pneumoniae; Treatment Outcome | 2010 |